Background
Hamza Khairkhwah is a Clinical Independent Prescribing Pharmacist specialising in ADHD, medical weight management and male hormone health. He works across assessment, diagnosis and prescribing, and is known for a structured, methodical approach to complex presentations, taking each treatment plan through from first consultation to stable, well-monitored maintenance.
His practice is built around conditions where patients frequently face long waits or fragmented care. He places particular emphasis on shared decision-making, explaining the evidence, the options and the trade-offs clearly, so that patients understand the reasoning behind their treatment rather than simply receiving it.
Experience
Hamza has practised as a Clinical Independent Prescribing Pharmacist across private clinical services and primary care, managing a caseload spanning both NHS Right to Choose and private patients.
At Ready Health Private Medical Clinic, he conducts in-depth adult ADHD assessments using the DIVA-5 diagnostic interview, aligned to DSM-5 criteria, examining both childhood and adult symptomatology to reach a clear diagnostic formulation. He produces comprehensive clinical reports, initiates and optimises pharmacological treatment, and delivers structured psychoeducation and lifestyle guidance alongside medication.
He has held ADHD assessor and prescriber roles with Clinical Partners, CareADHD and Medinet (HealthHarmonie), covering assessments across the lifespan, triage and prioritisation for ADHD pathways, and the titration of both stimulant and non-stimulant medication. This work has included highly complex presentations with psychiatric and physical health comorbidities, cardiovascular risk assessment, and close liaison with GPs and multidisciplinary teams to establish shared care arrangements.
In weight management, Hamza has served as Senior and Lead Prescribing Pharmacist at PillSorted, and as a prescribing pharmacist with HeliosX/MedExpress and Dr Franks Clinic, assessing patient eligibility for GLP-1 therapy and managing both straightforward and complex cases. He authored the GLP-1 prescribing protocol at PillSorted, conducted the accompanying risk assessment, and led periodic review of patient screening questionnaires, including appropriate BMI thresholds for patients of South Asian and other minority ethnic backgrounds, where cardiometabolic risk presents at a lower BMI.
Earlier in his career he worked as a Clinical Pharmacist in general practice, delivering consultations for cardiovascular disease including hypertension and hyperlipidaemia, conducting structured medication reviews, managing discharge summaries, and monitoring high-risk medicines against blood results to support safe prescribing.
Specialisation
Hamza specialises in:
- Adult ADHD assessment and diagnosis (DIVA-5, DSM-5 criteria)
- ADHD medication titration, optimisation and long-term monitoring, including stimulant and non-stimulant therapy
- Shared care arrangements and GP liaison for ADHD patients
- Medical weight management, including prescribing of GLP-1 medications
- Male hormone health and testosterone optimisation
- Cardiovascular risk assessment and management
- Smoking cessation
He is SCOPE accredited by the World Obesity Federation and holds CPD-certified specialist qualifications in both ADHD diagnosis and ADHD management.
Educational Background
Hamza graduated from the University of Bradford in 2021 with a First Class Master of Pharmacy (MPharm) degree, having completed a Foundation Year in Clinical Sciences at the same institution. He subsequently qualified as an independent prescriber through the University of Bradford's Prescribing for Pharmacists programme.
His postgraduate training includes:
- Strategic Centre for Obesity Professional Education (SCOPE) – World Obesity Federation, 2024
- ADHD Specialist in Diagnosis – CPD certified, 2025
- ADHD Specialist in Management – CPD certified, 2025
- Certified Smoking Cessation Practitioner – National Centre for Smoking Cessation and Training (NCSCT), 2024
Research Interest
Hamza is interested in work that explores:
- Safe and effective pharmacist-led assessment and titration in adult ADHD services
- Managing ADHD in the presence of psychiatric and cardiovascular comorbidity
- Long-term outcomes and weight maintenance following GLP-1 therapy
- Ethnicity-adjusted BMI thresholds and equitable access to weight management treatment
- Improving access to specialist care through community-based private services
Research Summary
Hamza has led protocol development and clinical governance work within private prescribing services. He authored the GLP-1 injection prescribing protocol and its accompanying risk assessment at PillSorted, where he also conducted clinical audit, six-monthly clinical progress reviews, and periodic revision of patient screening questionnaires.
Across his ADHD practice he works to NICE-aligned pathways, maintaining rigorous documentation and prescribing-safety standards, and contributes to service evaluation to ensure clinical pathways remain evidence-based and safely governed.
Professional Affiliations
- General Pharmaceutical Council (GPhC) – Registered Pharmacist and Independent Prescriber (Reg. 2228294)
- World Obesity Federation – SCOPE accredited